Question 1

What specific information will this study provide about venetoclax?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting clinical trial (NCT03342144). Contact the study team or your healthcare provider for specific answers.

Question 2

How will participating in this study impact my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting clinical trial (NCT03342144). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting clinical trial (NCT03342144). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting clinical trial (NCT03342144). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of information will I need to report during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting clinical trial (NCT03342144). Contact the study team or your healthcare provider for specific answers.

What this study is about